期刊文献+

河北省不同精神障碍患者药物使用现况调查 被引量:4

Cross-sectional study on drug patterns of mental disorder in Hebei province
原文传递
导出
摘要 目的分析2012年河北省不同精神障碍患者药物的使用情况。方法纳入2012年河北省在门诊和住院的3种常见精神障碍患者4221例,用自制问卷进行调查并进行分析。结果在精神分裂症患者中,69.2%接受单一药物治疗,30.8%联合使用2种及其以上抗精神病药,且住院患者联合用药比例明显高于门诊患者(P<0.01)。双相障碍患者中,87.3%用抗精神病药,76.4%用心境稳定剂,29.2%用苯二氮类药物;联用2种及其以上药物治疗的比例占82.5%。在抑郁症患者中,95.6%接受抗抑郁药治疗,合并药物主要是苯二氮类药物(41.4%)。结论河北省3种常见精神障碍患者的药物处方方式基本合理。 Objective To analyse the medication treatment patterns of mental disorder in Hebei province in 2012. Methods A total of the 4221 patients inciuding outpatient and inpatient, who were diagnosed with schizophrenia, bipolar mania and depression from Hebei province were selected and investigated with self-made questionnaire. Results The 69.2% patients of schizophrenia were treated with mono - pharma- cy 30. 8% were treated with at least two antipsychotics. More inpatients use combined antipsych0tics than outpatients (P 〈 0. 01 ). The 87. 3% patients of bipolar disorder were treated with antipsychotic agents, 76. 4% with mood stabilizers, 29.2% with the benzodiazepine. And most of the bipolar disorder patients (82. 5% ) were treated with psychiatric medications. The 95.6% patients of depression were treated with antidepressants. The cOmmon concomitant medication were benzodi- azepine (41.4%). Conclusion The drug patterns of schizophrenia, bipolar disorder and depression in Hebei province are rational.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2014年第10期942-945,共4页 The Chinese Journal of Clinical Pharmacology
基金 河北省医学科学研究重点课题计划基金资助项目(20130076)
关键词 精神障碍 抽样研究 处方 抗精神病药 抗抑郁药 mental disorder sampling study prescription antipsychotics antidepressant
  • 相关文献

参考文献21

  • 1Steel Z, Mamane C, Iranpour C,ei al. The global prevalence ofcommon mental disorders : a systematic review and meta - analysis1980-2013[J]. Int J Epidemiol6 -493.
  • 2Seedat S, Scott KM, Angermeyer MC, et al. Cross - national asso-ciations between gender and mental disorders in the World HealthOrganization World Mental Health Surveys[ J]. Arch Gen PsychicU,2009,66:785 -795.
  • 3Kessler RC, Ormel J, Petukhova M,et al. Development of lifetimecomorbidity in the World Health Organization world mental healthsurveys [J]. Arch Gen Psychiat,2011,68:90 - 100.
  • 4Ramos MA. Drugs in context : a historical perspective on theories ofpsychopharmaceutical efficacy [ J ]. J New Ment Dis,2013,201:926-933.
  • 5Ban TA. Pharmacotherapy of mental illness一a historical analysis[J]. Prog Neuropsychopharmacol Biol Psychiat,2001,25:709* -727.
  • 6中华医学会.精神分裂症防治指南[M].北京:北京大学医学出版社,2007,55:26.
  • 7Karthik MS, Wsrikoo N, Chakrabarti S,ef al. Attitudes towards an-tipsychotics among patients with schizophrenia on first - orsecond - generation medications[ J]. Indian J Psychol Med, 2014,36: 288 - 293.
  • 8Paric T, Kuntz KM. Cost - effectiveness of second - generation anti-psychotics for the treatment of schizophrenia [ J ]. Value Health,2014,17;310-319.
  • 9司天梅,陈旭先.精神分裂症患者使用长效抗精神病药物的现况调查[J].中国神经精神疾病杂志,2007,33(10):620-622. 被引量:9
  • 10Bera RB. Patient outcomes within schizophrenia treatment: a look atthe role of long - acting injectable antipsychotics[ J]. J Clin Psy-chiat ,2014,75(Suppl. 2):S30-S33.

二级参考文献9

  • 1沈渔邨.精神病学(第四版)[M].北京:人民卫生出版社,2003.448-453.
  • 2Kane JM. Review of treatments that can ameliorate nonadherence in patients with schizophrenia. Journal of Clinical Psychiatry, 2006, 67 ( Suppl 5 ) : 9.
  • 3Adams CE, Fenton MKP, Quraishi S, et al. Systematic meta-review of depot antipsychotic drugs for people with schizophrenia. British Journal of Psychiatry, 2001, 179(10) : 290.
  • 4Bloch Y, Mendlovic S, Strupinsky S, et al. Injections of depot antipsychotic medications in patients suffering from schizophrenia: do they hurt? Journal of Clinical Psychiatry, 2001, 62 (11 ) : 855.
  • 5Walburn J, Gray R, Goumay K, et al. Systematic review of patient and nurse attitudes to depot antipsychotic medication. British Journal of Psychiatry, 2001, 179(10) : 300.
  • 6世界卫生组织.ICD10精神和行为障碍分类.北京:人民卫生出版社.1993.72-79.
  • 7Sim K, Su A, Ungvari GS, et al. Depot antipsychotic use in schizophrenia: an East Asian perspective. Hum-Psychopharmacol, 2004, 19(2) : 103.
  • 8Castle D, Morgan V, Jablensky A. Antipsychotic use in Australia: the patients' perspective. Australian and New Zealand Journal of Psychiatry, 2002, 36(5): 633.
  • 9朱丽萍,高哲石,宋立升.长期合用安坦对氯丙嗪血药浓度的影响[J].上海精神医学,1997,9(A00):243-245. 被引量:5

共引文献23

同被引文献37

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部